Higher diet quality associated with reduced risk of prostate cancer grade reclassification

A study in JAMA Oncology links dietary quality to prostate cancer grade reclassification risk, suggesting healthier diets may reduce progression in early cases.

Sponsors urged to compensate oncology patients and meet trial staff face-to-face – Pharmaceutical Technology

Traditionally oncology patients have not been compensated for participating in clinical trials. Credit: Shutterstock / Kunlanan Yarist Sponsors are being urged to compensate participants in

October 24, 2023

Study provides key insights into the communication process surrounding innovative surgical procedures

Patients are not given sufficient information about the novel status of a procedure, possible uncertainties or potential risks when deciding to go ahead with the

August 14, 2023

Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024 – Biotech Investments

Medacta Group SA / Key word(s): Miscellaneous Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024 12.02.2024 / 19:00 CET/CEST MEDIA RELEASE

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.